Article

Concomitant Analysis of EZH2 and ASXL1 Mutations In Myelofibrosis, Chronic Myelomonocytic Leukemia and Blast-Phase Myeloproliferative Neoplasms

2010-11-19

Abstract excerpt

Abstract Abstract 3070 Background: EZH2 and ASXL1 mutations were recently described in a spectrum of myeloid malignancies; mutational analysis of small patient cohorts has suggested the highest mutational frequency in myelofibrosis (MF) and chronic myelomonocytic leukemia (CMML). The current study seeks to determine i) EZH2 and ASXL1 mutational frequencies in WHO-defined subcategories of MF, CMML and blast-phase m...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d9881aad-7949-5fb6-9a96-d430eeccf9a0
DOI: 10.1182/blood.v116.21.3070.3070

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Concomitant Analysis of EZH2 and ASXL1 Mutations In Myelofibrosis, Chronic Myelomonocytic Leukemia and Blast-Phase Myeloproliferative NeoplasmsDOI 10.1182/blood.v116.21.3070.3070Read

Targeted next-generation sequencing in blast phase myeloproliferative neoplasms.Semantic proximity Read

Mutational landscape of blast phase myeloproliferative neoplasms (MPN-BP) and antecedent MPN.Semantic proximity Read

Combination of myeloproliferative neoplasm driver gene activation with mutations of splice factor or epigenetic modifier genes increases risk of rapid blastic progression.Semantic proximity Read

Genetic evolution of myeloproliferative neoplasms from chronic phase to blastic phase: An analysis of 46 paired samplesSemantic proximity Read

Current outlook on molecular pathogenesis and treatment of myeloproliferative neoplasms.Semantic proximity Read

Comparison of the Mutational Profiles of Primary Myelofibrosis, Polycythemia Vera, and Essential ThrombocytosisSemantic proximity Read

Role of TET2 and ASXL1 mutations in the pathogenesis of myeloproliferative neoplasms.Semantic proximity Read

TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis.Semantic proximity Read

EZH2 mutational status predicts poor survival in myelofibrosis.Semantic proximity Read

Blast phase myeloproliferative neoplasm: contemporary review and 2024 treatment algorithm.Semantic proximity Read

Mutation analysis of <i>ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12,</i> and <i>TET2</i> in myeloproliferative neoplasmsSemantic proximity Read

Accelerated and blast phase myeloproliferative neoplasms.Semantic proximity Read